216 related articles for article (PubMed ID: 20872895)
21. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
22. Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic - Spectralprint recognition study.
El-Hanboushy S; Marzouk HM; Fayez YM; Abdelkawy M; Lotfy HM
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Nov; 280():121523. PubMed ID: 35759933
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
de la Sierra A; Barrios V
Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
[TBL] [Abstract][Full Text] [Related]
24. Validation of a capillary electrophoresis method for the simultaneous determination of amlodipine besylate and valsartan in pharmaceuticals and human plasma.
Alnajjar AO
J AOAC Int; 2011; 94(2):498-502. PubMed ID: 21563683
[TBL] [Abstract][Full Text] [Related]
25. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
Khan W; Moin N; Iktidar S; Sakrani J; Abid R; Afzal J; Maheshwary N; Kumar K; Siddiqi A; Qadir M
Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
[TBL] [Abstract][Full Text] [Related]
26. Application of MEKC and UPLC with Fluorescence Detection for Simultaneous Determination of Amlodipine Besylate and Bisoprolol Fumarate.
Elonsy SM; El Yazbi FA; Shaalan RA; Ahmed HM; Belal TS
J AOAC Int; 2021 May; 104(2):339-347. PubMed ID: 33259587
[TBL] [Abstract][Full Text] [Related]
27. Stripping voltammetric determination of valsartan in bulk and pharmaceutical products.
Habib IH; Weshahy SA; Toubar SS; el-Alamin MM
Pharmazie; 2008 May; 63(5):337-41. PubMed ID: 18557415
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of binary mixture of amlodipine besylate and atenolol based on dual wavelengths.
Lamie NT
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 149():201-7. PubMed ID: 25958126
[TBL] [Abstract][Full Text] [Related]
29. New methods for amlodipine and valsartan native spectrofluorimetric determination, with factors optimization study.
El-Kosasy AM; Tawakkol SM; Ayad MF; Sheta AI
Talanta; 2015 Oct; 143():402-413. PubMed ID: 26078177
[TBL] [Abstract][Full Text] [Related]
30. Novel Pure Component Contribution Algorithm (PCCA) and UHPLC Methods for Separation and Quantification of Amlodipine, Valsartan, and Hydrochlorothiazide in Ternary Mixture.
Mowaka S; Hegazy MA; Lotfy HM; Mohamed EH
J AOAC Int; 2017 May; 100(3):692-699. PubMed ID: 28118578
[TBL] [Abstract][Full Text] [Related]
31. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
32. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
33. Validated spectrofluorometric methods for determination of amlodipine besylate in tablets.
Abdel-Wadood HM; Mohamed NA; Mahmoud AM
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Aug; 70(3):564-70. PubMed ID: 17889593
[TBL] [Abstract][Full Text] [Related]
34. [Medication of the month. Exforge HCT: combination of amlodipine besylate, valsartan and hydrochlorothiazide in a single tablet].
Lancellotti P
Rev Med Liege; 2010; 65(7-8):471-5. PubMed ID: 20857707
[TBL] [Abstract][Full Text] [Related]
35. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
Deeks ED
Am J Cardiovasc Drugs; 2009; 9(6):411-8. PubMed ID: 19929039
[TBL] [Abstract][Full Text] [Related]
36. Improved analytical validation and pharmacokinetics of valsartan using HPLC with UV detection.
Piao ZZ; Lee ES; Tran HT; Lee BJ
Arch Pharm Res; 2008 Aug; 31(8):1055-9. PubMed ID: 18787797
[TBL] [Abstract][Full Text] [Related]
37. A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets.
Mohammadi A; Rezanour N; Ansari Dogaheh M; Ghorbani Bidkorbeh F; Hashem M; Walker RB
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):215-21. PubMed ID: 17010681
[TBL] [Abstract][Full Text] [Related]
38. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
39. Validated spectrophotometric methods for the determination of amlodipine besylate in drug formulations using 2,3-dichloro 5,6-dicyano 1,4-benzoquinone and ascorbic acid.
Rahman N; Nasrul Hoda M
J Pharm Biomed Anal; 2003 Feb; 31(2):381-92. PubMed ID: 12609678
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
